dihydroxyphenylalanine has been researched along with Adenoma, Prolactin-Secreting, Pituitary in 4 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ginet, M | 1 |
Cuny, T | 1 |
Schmitt, E | 1 |
Marie, PY | 1 |
Verger, A | 1 |
Heimburger, C | 1 |
Bund, C | 1 |
Addeo, P | 1 |
Goichot, B | 1 |
Imperiale, A | 1 |
Bancos, I | 1 |
Nippoldt, TB | 1 |
Erickson, D | 1 |
Schuff, KG | 1 |
Hentges, ST | 1 |
Kelly, MA | 1 |
Binart, N | 1 |
Kelly, PA | 1 |
Iuvone, PM | 1 |
Asa, SL | 1 |
Low, MJ | 1 |
4 other studies available for dihydroxyphenylalanine and Adenoma, Prolactin-Secreting, Pituitary
Article | Year |
---|---|
18F-FDOPA PET Imaging in Prolactinoma.
Topics: Dihydroxyphenylalanine; Humans; Male; Middle Aged; Pituitary Neoplasms; Positron-Emission Tomography | 2017 |
18F-FDOPA Uptake Reflects the Efficacy of Dopamine Agonists Treatment in Pituitary Prolactinoma.
Topics: Adult; Bone Neoplasms; Dihydroxyphenylalanine; Dopamine Agonists; Female; Humans; Magnetic Resonance | 2018 |
Hypersexuality in men with prolactinomas treated with dopamine agonists.
Topics: Dihydroxyphenylalanine; Dopamine Agonists; Humans; Male; Pituitary Neoplasms; Prolactinoma; Puberty, | 2017 |
Lack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and -independent mechanisms.
Topics: Animals; Cell Division; Dihydroxyphenylalanine; Dopamine; Female; Hypothalamus; Male; Mice; Mice, In | 2002 |